
Avid Bioservices CDMO
Quarterly report 2024-Q3
added 12-10-2024
Avid Bioservices DIO Ratio 2011-2026 | CDMO
Annual DIO Ratio Avid Bioservices
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102 | 129 | 112 | 62.4 | 71.2 | 51.6 | 104 | 316 | 257 | 172 | 154 | 126 | 130 | 264 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 316 | 51.6 | 147 |
Quarterly DIO Ratio Avid Bioservices
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.5 | 78.9 | - | 106 | 121 | 115 | - | 97.3 | 103 | 93.3 | - | 94.3 | 95.8 | 34.1 | - | 68.8 | 60.2 | 63.8 | 52.9 | 64 | 48.3 | 22.9 | - | 99.8 | 87.6 | 80.8 | 168 | - | 114 | 128 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 168 | 22.9 | 86.4 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.09 | -0.97 % | $ 437 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 23.66 | 0.11 % | $ 3.01 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Ardelyx
ARDX
|
989 | $ 5.97 | 0.51 % | $ 1.44 B | ||
|
CASI Pharmaceuticals
CASI
|
47.4 | - | - | $ 35.4 M |